Page last updated: 2024-09-05

deflazacort and Cardiac Diseases

deflazacort has been researched along with Cardiac Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giannakopoulou, A; Karanasios, E; Kolovou, G; Markousis-Mavrogenis, G; Mavrogeni, S; Noutsias, M; Papadopoulos, G; Papavasiliou, A; Pons, R1
Agüero, J; Almenar Bonet, L; Martínez-Dolz, L; Moro, JA; Raso, R; Salvador, A; Sánchez-Lázaro, I1

Trials

1 trial(s) available for deflazacort and Cardiac Diseases

ArticleYear
Randomized prospective study of the evolution of renal function depending on the anticalcineurin used.
    Transplantation proceedings, 2008, Volume: 40, Issue:9

    Topics: Aged; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Mycophenolic Acid; Pregnenediones; Tacrolimus

2008

Other Studies

1 other study(ies) available for deflazacort and Cardiac Diseases

ArticleYear
Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
    BMC cardiovascular disorders, 2017, 07-24, Volume: 17, Issue:1

    Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Asymptomatic Diseases; Case-Control Studies; Child; Contrast Media; Cross-Sectional Studies; Echocardiography; Electrocardiography; Gadolinium DTPA; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Muscular Dystrophy, Duchenne; Perindopril; Pregnenediones; Protective Agents; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Function, Right

2017